Sanofi Pasteur Philippines General Manager Jean Antoine Zinsou maintained that the vaccine has been “proven safe and efficacious.”
“The fact is we have this revocation ongoing, and the fact is that we are open to any discussion with FDA because we want to turn to the future, for the benefit of the Filipinos. So, that’s what we want. We want to be able to discuss with FDA and see how this revocation can be reevaluated,” he added.
“The dengue vaccination issue has had an impact on many things here in the Philippines, so we definitely need to settle this issue–one way to do it is to discuss with FDA and see what is needed to have this revocation lifted,” he added. “We could not agree more. The vaccines that we are mentioning is not a solution or a silver bullet for the ongoing outbreak,” he said.
Pay more doctors to endorse your product.
this is a dead product, its name has its chilling effects to every human being alive in the Philippines, its return is just a wasteful proposition, no matter how much this multinational pay its medical (mal)practitioners to misinform the public